COVID-19 Project Topics: Difference between revisions
Jump to navigation
Jump to search
TayyabaAli (talk | contribs) Undo revision 1615017 by TayyabaAli (talk) Tag: Undo |
Gerald Chi- (talk | contribs) |
||
Line 5: | Line 5: | ||
{{WikiDoc CMG}}; {{AE}} {{Sahar}} | {{WikiDoc CMG}}; {{AE}} {{Sahar}} | ||
==List of All Topics== | ==List of All Topics== | ||
'''[[COVID-19|COVID-19 Main Page]]''' | |||
'''[[COVID-19 Organ-Based Complications]]''' | '''[[COVID-19 Organ-Based Complications]]''' | ||
* [[Cardiovascular Disorders and COVID-19|Cardiovascular disorders and COVID-19]] | * [[Cardiovascular Disorders and COVID-19|Cardiovascular disorders and COVID-19]] |
Revision as of 16:58, 23 June 2020
COVID-19 Project |
---|
Introduction |
Team |
Meetings' Summary |
Topics |
Ongoing Clinical Trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
List of All Topics
COVID-19 Organ-Based Complications
- Cardiovascular disorders and COVID-19
- Dermatologic disorders of COVID-19
- Gastrointestinal disorders and of COVID-19
- Hematologic disorders and COVID-19
- Nephrologic disorders and COVID-19
- Neurologic disorders and COVID-19
- Ongoing clinical trials of COVID-19
- Pulmonary disorders and COVID-19
- Pediatrics disorders and COVID-19